NIT
BIO icon

NumerixS Investment Technologies’s Bio-Rad Laboratories Class A BIO Stock Holding History

NumerixS Investment Technologies’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300
Closed -$135K – 110
2020
Q2 		$135K Sell
300
-100
-25% -$44.1K 0.04% 493
2020
Q1 		$140K Sell
400
-700
-64% -$257K 0.07% 332
2019
Q4 		$407K Buy
1,100
+900
+450% +$317K 0.08% 280
2019
Q3 		$67K Buy
+200
New +$65.2K 0.02% 656
2019
Q2 		– Sell
-1,200
Closed -$364K – 1079
2019
Q1 		$364K Buy
1,200
+248
+26% +$66.9K 0.05% 459
2018
Q4 		$219K Buy
+952
New +$255K 0.07% 319
2018
Q3 		– Sell
-100
Closed -$29K – 1197
2018
Q2 		$29K Sell
100
-1,100
-92% -$304K 0.01% 988
2018
Q1 		$297K Buy
1,200
+200
+20% +$50.9K 0.07% 295
2017
Q4 		$239K Sell
1,000
-100
-9% -$24.2K 0.05% 412
2017
Q3 		$244K Buy
1,100
+600
+120% +$135K 0.05% 459
2017
Q2 		$113K Buy
+500
New +$109K 0.02% 803

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NumerixS Investment Technologies's BIO Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 300 shares — an estimated $135K sold.

NumerixS Investment Technologies first reported a position in BIO in Q2 2017 and held it in 11 quarters. The position peaked at $407K in Q4 2019. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 300 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $135K.
  • NumerixS Investment Technologies first reported a position in Bio-Rad Laboratories Class A in Q2 2017 and held it in 11 quarters.
  • NumerixS Investment Technologies's Bio-Rad Laboratories Class A position peaked at $407K in Q4 2019.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.